| Page 1396 | Kisaco Research
 

Yasha Talaga

Head of Sales
Millipore Sigma

Yasha Talaga

Head of Sales
Millipore Sigma

Yasha Talaga

Head of Sales
Millipore Sigma
 

Adam Didier

R&D Scientist
Millipore Sigma

Adam Didier

R&D Scientist
Millipore Sigma

Adam Didier

R&D Scientist
Millipore Sigma
 

Traci Kyes

Director of Business Development
ArrantaBio

Traci Kyes

Director of Business Development
ArrantaBio

Traci Kyes

Director of Business Development
ArrantaBio
 

Tonya Ward

Senior Director of Bioinformatics & Laboratory Operations
Diversigen

Tonya Ward

Senior Director of Bioinformatics & Laboratory Operations
Diversigen

Tonya Ward

Senior Director of Bioinformatics & Laboratory Operations
Diversigen
 

Mark Plinio

Chief Commercial Officer
Evelo Biosciences

Mark Plinio

Chief Commercial Officer
Evelo Biosciences

Mark Plinio

Chief Commercial Officer
Evelo Biosciences
 

Ann Marie Conway

Vice President of Clinical Operations
Finch Therapeutics

Ann Marie Conway

Vice President of Clinical Operations
Finch Therapeutics

Ann Marie Conway

Vice President of Clinical Operations
Finch Therapeutics
 

Warren Flood

COO
Bio-me

Warren Flood

COO
Bio-me

Warren Flood

COO
Bio-me
 
Petcare Innovation Summit Europe 2022
17-18 May 2022
London, UK
150+ industry executives, from strategic buyers, financial buyers and independent pet brands, all looking for their next investment, acquisition or business partnering opportunity.
 

Cecile Teles

Head of IP
Zentiva

Cecile is Head Patent Attorney at Zentiva. She has over a decade of experience in the pharmaceutical industry.

Cecile is uniquely experienced and knowledgeable in the pharma space as she has experience in-house at an elite innovator company (Sanofi), biologics (Merck Serono), and extensive generic experience she gained as Zentiva.

Cecile is an enthusiastic manager of her team and was a key member of the IP team in leading the transformation of Zentiva into an independent and competitive generic company after divestment from Sanofi.

Cecile Teles

Head of IP
Zentiva

Cecile Teles

Head of IP
Zentiva

Cecile is Head Patent Attorney at Zentiva. She has over a decade of experience in the pharmaceutical industry.

Cecile is uniquely experienced and knowledgeable in the pharma space as she has experience in-house at an elite innovator company (Sanofi), biologics (Merck Serono), and extensive generic experience she gained as Zentiva.

Cecile is an enthusiastic manager of her team and was a key member of the IP team in leading the transformation of Zentiva into an independent and competitive generic company after divestment from Sanofi.

Cecile is a qualified European Patent Attorney. She also holds a certificate from CEIPI in patent litigation and most recently completed her diploma as a Master of Laws in France.

 

Matthijs van den Bos

Lead Engineer Blockchain
ING Group

Matthijs van den Bos is a Lead Engineer at ING Bank's Center of Expertise for Blockchain, focusing on solving blockchain privacy challenges.

On behalf of ING, he is CTO for ZKFlow (zkflow.io), which brings confidential transactions to Corda using Zero Knowledge Proofs. Matthijs has been developing on Corda since 2016 and has previously been involved as CTO in one of R3's earliest Corda initiatives to reach production status.

Before joining ING, Matthijs worked in different technology positions in various industries throughout his twenty-year career.

Matthijs van den Bos

Lead Engineer Blockchain
ING Group

Matthijs van den Bos

Lead Engineer Blockchain
ING Group

Matthijs van den Bos is a Lead Engineer at ING Bank's Center of Expertise for Blockchain, focusing on solving blockchain privacy challenges.

On behalf of ING, he is CTO for ZKFlow (zkflow.io), which brings confidential transactions to Corda using Zero Knowledge Proofs. Matthijs has been developing on Corda since 2016 and has previously been involved as CTO in one of R3's earliest Corda initiatives to reach production status.

Before joining ING, Matthijs worked in different technology positions in various industries throughout his twenty-year career.